243 related articles for article (PubMed ID: 30509980)
1. Probing the mechanism of inhibition of amyloid-β(1-42)-induced neurotoxicity by the chaperonin GroEL.
Wälti MA; Steiner J; Meng F; Chung HS; Louis JM; Ghirlando R; Tugarinov V; Nath A; Clore GM
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11924-E11932. PubMed ID: 30509980
[TBL] [Abstract][Full Text] [Related]
2. Suppression of amyloid fibrils using the GroEL apical domain.
Ojha B; Fukui N; Hongo K; Mizobata T; Kawata Y
Sci Rep; 2016 Aug; 6():31041. PubMed ID: 27488469
[TBL] [Abstract][Full Text] [Related]
3. Chaperonin GroEL accelerates protofibril formation and decorates fibrils of the Het-s prion protein.
Wälti MA; Schmidt T; Murray DT; Wang H; Hinshaw JE; Clore GM
Proc Natl Acad Sci U S A; 2017 Aug; 114(34):9104-9109. PubMed ID: 28784759
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of Inter-Molecular Interactions Between Single Aβ
Feng L; Watanabe H; Molino P; Wallace GG; Phung SL; Uchihashi T; Higgins MJ
J Mol Biol; 2019 Jul; 431(15):2687-2699. PubMed ID: 31075274
[TBL] [Abstract][Full Text] [Related]
5. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
Gu L; Tran J; Jiang L; Guo Z
J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
[TBL] [Abstract][Full Text] [Related]
6. Modulating the Effects of the Bacterial Chaperonin GroEL on Fibrillogenic Polypeptides through Modification of Domain Hinge Architecture.
Fukui N; Araki K; Hongo K; Mizobata T; Kawata Y
J Biol Chem; 2016 Nov; 291(48):25217-25226. PubMed ID: 27742838
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the secondary structure of beta-amyloid (Abeta42) fibrils by systematic proline replacement.
Morimoto A; Irie K; Murakami K; Masuda Y; Ohigashi H; Nagao M; Fukuda H; Shimizu T; Shirasawa T
J Biol Chem; 2004 Dec; 279(50):52781-8. PubMed ID: 15459202
[TBL] [Abstract][Full Text] [Related]
8. Probing the transient dark state of substrate binding to GroEL by relaxation-based solution NMR.
Libich DS; Fawzi NL; Ying J; Clore GM
Proc Natl Acad Sci U S A; 2013 Jul; 110(28):11361-6. PubMed ID: 23798407
[TBL] [Abstract][Full Text] [Related]
9. Probing the Interaction of Huntingtin Exon-1 Polypeptides with the Chaperonin Nanomachine GroEL.
Wälti MA; Kotler SA; Clore GM
Chembiochem; 2021 Jun; 22(11):1985-1991. PubMed ID: 33644966
[TBL] [Abstract][Full Text] [Related]
10. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
Dong M; Zhao W; Hu D; Ai H; Kang B
ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of Nucleated Conformational Conversion of Aβ42.
Fu Z; Aucoin D; Davis J; Van Nostrand WE; Smith SO
Biochemistry; 2015 Jul; 54(27):4197-207. PubMed ID: 26069943
[TBL] [Abstract][Full Text] [Related]
12. Kinetic Insights into Zn
Guo J; Yu L; Sun Y; Dong X
J Phys Chem B; 2017 Apr; 121(16):3909-3917. PubMed ID: 28378589
[TBL] [Abstract][Full Text] [Related]
13. In silico investigation on the inhibition of Aβ
Dutta M; Mattaparthi VSK
J Biomol Struct Dyn; 2018 Feb; 36(3):741-752. PubMed ID: 28278027
[TBL] [Abstract][Full Text] [Related]
14. Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Abeta42 peptide.
Kim W; Hecht MH
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15824-9. PubMed ID: 17038501
[TBL] [Abstract][Full Text] [Related]
15. Toward the Mode of Action of the Clinical Stage All-d-Enantiomeric Peptide RD2 on Aβ42 Aggregation.
Zhang T; Gering I; Kutzsche J; Nagel-Steger L; Willbold D
ACS Chem Neurosci; 2019 Dec; 10(12):4800-4809. PubMed ID: 31710458
[TBL] [Abstract][Full Text] [Related]
16. An Aβ42 variant that inhibits intra- and extracellular amyloid aggregation and enhances cell viability.
Oren O; Banerjee V; Taube R; Papo N
Biochem J; 2018 Oct; 475(19):3087-3103. PubMed ID: 30213841
[TBL] [Abstract][Full Text] [Related]
17. NMR characterization of the interaction of GroEL with amyloid β as a model ligand.
Yagi-Utsumi M; Kunihara T; Nakamura T; Uekusa Y; Makabe K; Kuwajima K; Kato K
FEBS Lett; 2013 Jun; 587(11):1605-9. PubMed ID: 23603391
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Aβ
Vilasi S; Carrotta R; Ricci C; Rappa GC; Librizzi F; Martorana V; Ortore MG; Mangione MR
ACS Chem Neurosci; 2019 Aug; 10(8):3565-3574. PubMed ID: 31298838
[TBL] [Abstract][Full Text] [Related]
19. Probing the interaction mechanisms between transmembrane peptides and the chaperonin GroEL with fluorescence anisotropy.
Wang X; Chen H; Lu X; Chi H; Li S; Huang F
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Apr; 194():1-7. PubMed ID: 29304433
[TBL] [Abstract][Full Text] [Related]
20. Single point mutations induce a switch in the molecular mechanism of the aggregation of the Alzheimer's disease associated Aβ42 peptide.
Bolognesi B; Cohen SI; Aran Terol P; Esbjörner EK; Giorgetti S; Mossuto MF; Natalello A; Brorsson AC; Knowles TP; Dobson CM; Luheshi LM
ACS Chem Biol; 2014 Feb; 9(2):378-82. PubMed ID: 24199868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
